References:
1.American diabetes association. Diagnosis and classification of diabetes mellitus. Diabetes care2013;36(Supplement 1):S67-74
2.Hilliard Me, Sparling KM, Hitchcock J, Oser Tk, Hood KK. The emerging diabetes online community. Curr Diabetes Rev.2015;11(4):261-72.
3.Atkinson MA, Eisenbarth GS, Michels AW.Type 1 diabetes.Lancet.2014;383(9911):69-82.
4.Stamler J, Vaccaro O, Neaton JD, Wentworth D, Group MRFITR. Diabetes, other risk factors and 12 –yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care.1993;16(2):434-44.
5.International Diabetes federation: IDF Diabetes Atlas(2017)http://www.idf.org/idf-diabetes-atlas-eight-edition.Accessed Jan 2018.
6.CharlesAK,Grepstad M, VisintinE, FerrarioA. The economic burden of diabetes in India: a review of the literature. Glob health.2014;10(8):2-18.
7.Holla R, Prabhu S, Shetty, Deshpande S, Balla S, Hegde S,et al. Awareness about diabetes among adolescents of Mangalore, South India.NUJHS.2014;4(2):118-20.
8.Kansra P. Economic burden of diabetes among women: a comparison of out patient and inpatient care. J Health Manag.2018;20(3):401-9.
9.Knowler Wc, Barrett-Connor-E, Fowler SE, Hamman RF, Lachin JM, Walker EA,etal. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med.2002;346(6):393-403.
10.Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, etal. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and diabetes study. Diabetes care.1997;20(4):537-44.
11.Ramachandran A, Snehalatha C, Mary S, Mukesh b, Bhaskar AD, VijY V,etal. The indian diabetes prevention programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance(IDPP-1). Diabetologia 2006;49(2):289-97.
12.Tuomilehto J, Lindstorm J, Eriksson JG, Valle TT, Hamalainen H, Ilanne Parikka P etal. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med.2001;344(18):1343-50.
13.Ajala O, English P,Pinkney J. Systemic review and meta analysis of different dietary approaches to the management of type 2 diabetes. Am J Clin Nutr.2013;97(3):505-16.
14.N.D Guess,” Dietary interventions for the prevention of type 2 diabetes in high risk groups: current state of evidence and future research needs,”Nutrients,vol.10,no. 9,2018
15.S.Furmli,R. Elmasry, M. Ramos, and J.Fung,” therapeutic use of intermittent fasting for people with type 2 diabetes as an alternative to insulin,” BMJ Case Rep .,p.ber-2017:2218 -54.
16.Ford ES, Zhao G, Li C.Prediabetes and the risk for cardiovascular disease: a systematic review of the evidence. J Am Coll Cardiol.2010;55(13):1310-7.
17.Tabak AG, Herder C, Rathmann W,Brunner EJ, Kivimaki M.Prediabetes:a high risk state for diabetes development.Lancet.2012;379(9833):2279-90.
18.Warren B, Pankow JS, Matsushita K, Punjabi NM, Dava NR,Grams M,etal. Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the atherosclerosis risk in communities(ARIC)study. Lancet diabetes endocrinol.2017;5(1):34-42.
19. World health O, International diabetes F. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation. Geneva: world health organisation; 2006.
20. Yesudian CA, Grepstad M,Visintin E, Ferrario A. The economic burden of DM in india: a review of the literature. Glob Health. 2014;10(1):80.
21.Tripathy JP, Prasad BM. Cost of diabetic care in india : An inequitable picture. Diabetes Metab Syndr Clin Res Rev.2018;12(3):251-5.
22.Umpierrez G, Korythowski M. Diabetic emergencies -ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nat Rev Endocrinal 2016;12:222-232.
23.Fadini GP, Bonora BM, Avogaro A.SGLT2 inhibitors and diabetic ketoacidosis: data from the FDA adverse event reporting system. Diabetologia 2017;60:1385-1389
24.Hurskainen A, Virtanen J, Tuomainen T, Nurmi T,Voutilainen S. Association of serum 25-hydroxy vitamin D with type 2 Diabetes and markers of insulin resistance in a general older population in Finland. Diabetes Metab Res Rev 2012;28:418-23.
25.Pittas, A., Nelson, J., Mitri, J., Hillmann, W., Garganta, C., Nathan, D. et al Plasma 25-
hydroxyvitamin D and progression to diabetes in patients at risk for diabetes: an ancillary
analysis in the Diabetes Prevention Program. Diabetes Care. 2012;35: 565–573.
26. Kostoglou-Athanassiou I, Athanassiou P, Gkountouvas A, Kaldrymides P. Vitamin D and glycaemic control in Diabetes Mellitus Type 2 .Ther Adv Endocrinol Metab.2013;4(4):122-8.
27. Need, A., O’Loughlin, P., Horowitz, M. and Nordin, B. Relationship between fasting serum glucose, age, body mass index and serum 25 hydroxyvitamin D in postmenopausal women. Clin Endocrinol (Oxford) 2005; 62: 738–41.
28. Lim, S., Kim, M., Choi, S., Shin, C., Park, K., Jang, H. et al. Association of vitamin D deficiency with incidence of Type 2 Diabetesin high-risk Asian subjects. Am J Clin Nutr 2013; 97: 524–530.
29.Cavalier E, Delanaye P, Souberbielle JC, Radermecker RP. Vitamin D and Type 2
Diabetes Mellitus: where do we stand? Diabetes Metab. 2011 Sep;37(4):265-72.
30.Li YX, Zhou L. Vitamin D Deficiency, Obesity and Diabetes. Cell Mol Biol (Noisy-le- grand). 2015 Jun 10;61(3):35-8
31. Mezza T, Muscogiuri G, Sorice GP, Prioletta A, Salomone E, Pontecorvi A, Giaccari A. Vitamin D deficiency:a new risk factor for Type 2 diabetes? Ann Nutr Metab
2012;61:337-48.
32. Pittas, A., Lau, J., Hu, F. and Dawson-Hughes, B. The role of vitamin D and calcium in Type 2 diabetes. A systematic review and meta-analysis. J Clin Endoc Metab. 2007: 92: 2017–29.
33. Maestro B, Canpion J, Davila N,Calle C.(2000) Stimulation by 1, 21-dihydroxy vitamin- D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J 47: 383-391.
34.Talaei A, Mohamadi M, Adgi Z.(2013)The effect of vitamin D on insulin resistance in patients with type 2 Diabetes. Diabetol Metab syndr 5:8.
35.Cimbek A, Gursoy G, Kilic Z, Acar Y,D emirbas B,Bayram M,et al. Serum 25 hydroxy vitamin D3 levels in type 2 diabetic patients. Med BullHaseki.2013;51:89-94.
36.Simpson M,Brady H, Yin X, Seifert J, Barriga K, Hoffman M,et al.No association of vitamin D intake or 25-hydroxy vitamin D levels in childhood with risk of islet autoimmunity and type 1 Diabetes: the diabetes autoimmunity study in the young (DAISY). Diabetologia 2011;54(11):2779-88.
37.Araneta MRG, Kanaya A, Fugimoto W, et al.Optimum BMI cut points to screen Asian Americans for type 2 diabetes: The UCSD Filipino health study and the North Kohala study[Abstract].Diabetes 2014;63(Suppl. 1):A20.
38.Knowler WC, Barrett-Connor E, Fowler SE et al; Diabetes prevention programme research group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
39.Fedewa MV, Gist NH, Evans EM, Dishman RK. Exercise and insulin resistance in youth: a metanalysis. Pediatrics 2014;133:e163 e174.
40.Davis CL, Pollock NK, Waller JL,et al. Exercise dose and diabetes risk in overweight and obese children: a randomised controlled trial. JAMA 2012;308:1103 1112.